Tectonic Therapeutic grants 21,000 options to CSO
Tectonic Therapeutic’s Chief Scientific Officer received a 21,000-share stock option grant with staged vesting and a $29.92 exercise price.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tectonic Therapeutic, Inc. (TECX) reported that Chief Scientific Officer Peter McNamara received a grant of stock options for 21,000 shares of common stock on September 3, 2026. The options have an exercise price of $29.92 per share and expire on September 2, 2036. One-eighth of the options vest on September 3, 2026, with the remainder vesting in 42 equal monthly installments beginning October 3, 2026, subject to his continued service. No transactions were made under a Rule 10b5-1 trading plan, and McNamara now holds 21,000 options directly from this award.
Insider Trade Summary
Grant/Award: 21,000 shares
Grant/Award
1 txn
Insider
McNamara Peter
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) F1 | 21,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 21,000 contracts (Direct)
Footnotes (1)
- F1. 1/8th of the shares subject to the option vest on September 3, 2026 with the remaining shares subject to the option vesting in the following 42 equal monthly installments beginning on October 3, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Key Figures
Stock options granted: 21,000 options
Exercise price: $29.92 per share
Options held after transaction: 21,000 options
+3 more
6 metrics
Stock options granted
21,000 options
Grant to Chief Scientific Officer Peter McNamara on September 3, 2026
Exercise price
$29.92 per share
Exercise price for the 21,000 stock options granted September 3, 2026
Options held after transaction
21,000 options
Total stock options held directly by Peter McNamara following the reported grant
Expiration date
September 2, 2036
Expiration of the stock options granted to Peter McNamara
Initial vesting portion
1/8 of options
Vests on September 3, 2026, from the 21,000-option grant
Remaining vesting period
42 monthly installments
Equal monthly vesting installments beginning October 3, 2026
Key Terms
Employee Stock Option, vesting, installments, expiration date
4 terms
Employee Stock Option financial
"Employee Stock Option (Right to Buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
vesting financial
"the shares subject to the option vest on September 3, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
installments financial
"the remaining shares subject to the option vesting in the following 42 equal monthly installments"
Installments are a series of scheduled partial payments that together cover a larger amount owed or due, like paying for a purchase or loan in weekly or monthly pieces rather than all at once. For investors, installments matter because they change when cash moves between parties, affect a company’s or counterparty’s short-term cash flow and risk of missed payments, and can influence valuation or perceived financial stability much like spreading the cost of a car over monthly payments.
expiration date financial
"expire on September 2, 2036"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TECX disclose for Chief Scientific Officer Peter McNamara?
Tectonic Therapeutic disclosed that Chief Scientific Officer Peter McNamara received a grant of 21,000 stock options on September 3, 2026, giving him the right to buy common shares at a fixed exercise price, subject to the vesting schedule described in the filing.
What is the exercise price of the stock options granted to the TECX Chief Scientific Officer?
The stock options granted to Chief Scientific Officer Peter McNamara have an exercise price of $29.92 per share. This is the price at which he may purchase Tectonic Therapeutic common stock upon exercising the vested options.
How do the 21,000 TECX stock options granted to Peter McNamara vest?
The grant vests over time: one-eighth of the options vest on September 3, 2026, and the remaining shares vest in 42 equal monthly installments starting October 3, 2026, contingent on his continued service to Tectonic Therapeutic on each vesting date.
When do the newly granted TECX stock options to Peter McNamara expire?
The stock options granted to Peter McNamara expire on September 2, 2036. Any unexercised options after that expiration date will no longer be exercisable according to the terms disclosed.
How many TECX stock options does Peter McNamara hold after this transaction?
After this grant, Peter McNamara holds 21,000 stock options directly. This total corresponds to the full number of options covered by the September 3, 2026 award reported in the filing.
Were the TECX option transactions for Peter McNamara made under a Rule 10b5-1 plan?
No. The filing indicates that no Rule 10b5-1 trading plan was reported in connection with this stock option grant to Chief Scientific Officer Peter McNamara.
AI-generated analysis. How Rhea-AI works. Not financial advice.
